How Should We Treat Alectinib-Refractory ALK-Positive Non-Small Cell Lung Cancer?

J Thorac Oncol. 2018 Oct;13(10):1438-1440. doi: 10.1016/j.jtho.2018.07.009.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carbazoles
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Lung Neoplasms*
  • Organophosphorus Compounds
  • Piperidines
  • Pyrimidines
  • Receptor Protein-Tyrosine Kinases

Substances

  • Carbazoles
  • Organophosphorus Compounds
  • Piperidines
  • Pyrimidines
  • Receptor Protein-Tyrosine Kinases
  • brigatinib
  • alectinib